Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23428,1406,0.80 [0.73-0.88],2.659342796960228e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22997,3466,0.82 [0.78-0.88],3.9180434076079774e-10
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22957,3486,0.80 [0.76-0.85],3.34408016522104e-13
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23468,1044,0.78 [0.71-0.87],5.1430481382952186e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21472,1119,0.78 [0.70-0.86],1.0438826068797658e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,20714,1238,0.76 [0.69-0.84],1.3019687901237608e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16644,2266,0.79 [0.73-0.85],3.6689955573982725e-11
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23675,1251,0.78 [0.71-0.86],6.575989389841016e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Lung cancer and mesothelioma,15844,340,0.60 [0.51-0.71],2.115869970816489e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",18636,214,0.62 [0.51-0.76],2.9669948466400167e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23253,2785,0.82 [0.77-0.88],4.00661055312205e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23436,1472,0.77 [0.71-0.84],4.731113054706057e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23434,1470,0.77 [0.71-0.84],5.441960859257876e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21773,163,0.62 [0.51-0.76],3.4014248932125927e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,20371,1094,0.79 [0.72-0.88],7.1427042341019634e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,17450,272,0.64 [0.54-0.77],9.642349174358295e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,21058,3880,0.83 [0.79-0.88],9.147459573825372e-10
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,17363,185,0.62 [0.50-0.75],2.7624074204943003e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,17746,568,0.73 [0.64-0.84],5.926688919907606e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,17485,307,0.62 [0.53-0.73],1.1945299250271496e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,17559,381,0.66 [0.56-0.77],1.7890114558855385e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",17906,728,0.72 [0.64-0.81],4.5478999864741934e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,17751,573,0.67 [0.59-0.77],3.591711854175044e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,17566,388,0.62 [0.54-0.71],4.3877271685897805e-11
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22378,5200,0.83 [0.79-0.87],3.567820918199331e-13
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",18799,1621,0.70 [0.65-0.76],2.5795425518570378e-18
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,17978,800,0.74 [0.65-0.83],5.393713207046674e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Angina pectoris,20896,1488,0.80 [0.73-0.88],2.4047622251416497e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22561,250,0.62 [0.52-0.74],9.248054381609556e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,13948,2315,0.80 [0.74-0.86],1.2856702947174663e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Conduction disorders,19901,1370,0.80 [0.73-0.88],7.64331844357549e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22005,2621,0.83 [0.77-0.89],1.800816714183522e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,20059,7761,0.89 [0.85-0.93],3.606936533866214e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23507,1330,0.75 [0.69-0.82],1.073457368321279e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Hypertension,21259,6765,0.88 [0.84-0.92],1.1375412289675274e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21282,6788,0.88 [0.84-0.92],2.229562957702977e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",14677,183,0.56 [0.47-0.67],1.8738995289523768e-10
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Hypotension,23669,1239,0.78 [0.70-0.85],1.947748905675e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22149,2741,0.83 [0.77-0.88],3.26007145920997e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,19780,1249,0.77 [0.70-0.85],4.225668356348701e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23175,366,0.63 [0.55-0.73],7.956437448299506e-10
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22795,530,0.71 [0.62-0.82],1.3601798240021315e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23173,364,0.63 [0.55-0.73],6.867028880019322e-10
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,Any mental disorder,23128,3629,0.84 [0.79-0.89],2.428454746443877e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23556,585,0.72 [0.63-0.81],2.7461127236517004e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20672,1173,0.79 [0.72-0.87],2.75526000361436e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,Smoking dependency,23166,1533,0.81 [0.74-0.88],9.305145949312256e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21367,1868,0.79 [0.73-0.85],1.695822192445541e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23270,2211,0.77 [0.72-0.83],4.0175063047886026e-13
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",16584,1429,0.81 [0.74-0.88],2.5701491609942394e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",16908,1404,0.80 [0.73-0.87],7.898690543931126e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Bronchiectasis,20704,289,0.66 [0.55-0.78],2.7352730608936587e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22960,2545,0.78 [0.73-0.84],4.030839351590159e-13
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23591,1300,0.70 [0.64-0.76],4.369006918596718e-16
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21799,5267,0.80 [0.76-0.84],3.20870664691839e-20
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Emphysema,20762,347,0.65 [0.55-0.77],2.8080215315135605e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23565,2154,0.76 [0.71-0.82],5.4988905858083086e-14
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Later onset COPD,22748,996,0.69 [0.62-0.76],6.366043999323636e-13
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Other diseases of pleura,23534,2190,0.76 [0.71-0.82],1.208784592446304e-13
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23692,1384,0.77 [0.70-0.84],7.632039460663702e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Pleural effusion,22467,1123,0.77 [0.69-0.85],1.8158355473201208e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Pleural plaque,21609,265,0.63 [0.52-0.75],1.699259608890424e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23301,1890,0.75 [0.69-0.81],4.720889653455484e-14
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Constipation,23653,1597,0.81 [0.75-0.89],4.613794246491724e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19580,3054,0.86 [0.81-0.92],5.666425767948415e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18161,1635,0.80 [0.73-0.87],1.8264261807108506e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20271,6262,0.88 [0.84-0.93],3.11983645673615e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19225,2273,0.82 [0.76-0.88],1.156855894545384e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22802,1870,0.79 [0.73-0.86],1.447275557771039e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,21442,5588,0.89 [0.85-0.94],9.9924899328776e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22263,1537,0.81 [0.74-0.89],3.8758098297637385e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23513,2847,0.85 [0.79-0.90],1.1369346298909218e-06
